retatrutide mechanism triple agonist gip glp-1 glucagon retatrutide (LY-3437943) Market Analysis, 2033: Triple-Agonist Therapy Landscape In Obesity And Metabolic Disorders Retatrutide is a triple-agonist drug
Pay in 4 interest-free payments of $6.16 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 13 - Oct 18

















:max_bytes(150000):strip_icc()/Health-GettyImages-2112991427-c2c4d692054b4ff6933f01fc6c5be06c.jpg)





